Because C-reactive protein is considered to be a risk factor for cardiovascular disease [29], the presence of a systemic inflammatory component as evidenced by elevated concentrations of C-reactive protein in people with COPD may help to explain the increased risk for cardiovascular disease in this population. This evidence concerns the gene CRP and chronic obstructive pulmonary disease.